Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Carbon Health - Pasadena (Site 0149)

Pasadena, California 91101, United StatesNot linked to an institution yet

1running trial

Running trials

Active, not recruiting
Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes
NCT06008756· Phase 3· Merck Sharp & Dohme LLC· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – Carbon Health - Pasadena (Site 0149): trial site – Frontlight Research